Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purpose of this study was to characterize
myosin light chain kinase
(
MLCK
) expression in cardiac and skeletal muscle. The only classic
MLCK
detected in cardiac tissue, purified cardiac myocytes, and in a cardiac myocyte cell line (
AT1
) was identical to the 130-kDa smooth muscle
MLCK
(smMLCK). A complex pattern of
MLCK
expression was observed during differentiation of skeletal muscle in which the 220-kDa-long or "nonmuscle" form of
MLCK
is expressed in undifferentiated myoblasts. Subsequently, during myoblast differentiation, expression of the 220-kDa
MLCK
declines and expression of this form is replaced by the 130-kDa smMLCK and a skeletal muscle-specific isoform, skMLCK in adult skeletal muscle. These results demonstrate that the skMLCK is the only tissue-specific
MLCK
, being expressed in adult skeletal muscle but not in cardiac, smooth, or nonmuscle tissues. In contrast, the 130-kDa smMLCK is ubiquitous in all adult tissues, including skeletal and cardiac muscle, demonstrating that, although the 130-kDa smMLCK is expressed at highest levels in smooth muscle tissues, it is not a smooth muscle-specific protein.
...
PMID:Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. 1102 14